Home
About BEB
Curriculum
Admission
CNC Research
BEB in the Media
 
 
MIT-PORTUGAL PROGRAM 2015/2016 PRINCIPLES AND PRACTICE IN DRUG DEVELOPMENT - ELECTIVE COURSE
 
May 15 - 26
João Nuno Moreira, Luís Pereira de Almeida, Sérgio Simões, Stan Finkelstein
MIT-PORTUGAL PROGRAM 2015/2016
PRINCIPLES AND PRACTICE IN DRUG DEVELOPMENT - ELECTIVE COURSE
Center for Neuroscience and Cell Biology (CNC) - University of Coimbra

May 15 - May 26, 2017

João Nuno Moreira, Luís Pereira de Almeida, Sérgio Simões, Stan Finkelstein

Venue: CNC auditorium (Polo I); former Faculty of Medicine, 2nd floor, Rua Larga, 3004-504 Coimbra.

NOTE:
last minute changes to the program might take place; please take a look at the program on a daily basis.

May 15 - Monday
10.00 h - Introduction to the course
João Nuno Moreira - PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Luís Pereira de Almeida - PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Sérgio Simões - PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Stan N. Finkelstein - MD, PhD (Senior Research Assistant in the MIT Engineering Systems Division and Associate Professor of Medicine at Harvard Medical School)

11.00 h - The Pharmaceutical Industry and the Drug Development Process
Stan N. Finkelstein - MD, PhD (Senior Research Scientist in the MIT Engineering Systems Division and Associate Professor of Medicine, Harvard Medical School)

14.00 h - Basic Science I – Discovery Innovation and Emerging Technologies; Basic Business
Anthony J. Sinskey - PhD (Professor of Biology at MIT)

17.30 h - Building predictive models for oncology drug discovery
Darrin Stuart - PhD (Director, Cell Biology/Small Molecule Drug Discovery, Novartis Institutes for Biomedical Research, Cambridge, USA)

May 16 - Tuesday
09.30 h - FDA Process, Off-Label Prescribing, Insurance Coverage
Stan N. Finkelstein - MD, PhD (Senior Research Assistant in the MIT Engineering Systems Division and Associate Professor of Medicine at Harvard Medical School)

16:00 h - Re-Engineering the Drug Business
Robert Mulroy - Chairman and CEO of Partners Oncology, Inc

May 17 - Wednesday
10.00 h - Modeling chemistry and biology in drug discovery
Nuno Palma - PhD (BIAL, Indústria Farmacêutica, Portugal)

11.30 h - Development of small molecule inhibitors for treatment of CNS disorders
Laszlo Kiss - PhD (BIAL, Indústria Farmacêutica, Portugal)

14.30 h - Pharmacology and toxicology of new chemical entities
Lyndon C. Wright - PhD (BIAL, Indústria Farmacêutica, Portugal)

16:00 h - Clinical development of new chemical entities
Ana Santos - BSc (BIAL, Indústria Farmacêutica, Portugal)

May 18 - Thursday
10.30 h - Some issues in drug development: discussion of case studies
Miguel Prazeres - PhD (Instituto Superior Técnico, Technical University of Lisbon)

14.00 h - Visit to Biocant Park – Innovation Center in Biotechnology
(hired bus; meeting point: in front of the Department of Mathematics - Largo D. Dinis)

May 19 - Friday
10.30 h - From research to health care: regulatory affairs and regulatory science helping to shape an integrated healthcare system
Rogério Gaspar - PhD (iMed.UL and Faculty of Pharmacy, University of Lisbon)

15:00 - Translational research and the role of non clinical studies
Beatriz Silva Lima - PhD (Faculty of Pharmacy, University of Lisbon and President of the Scientific Council of the Innovative Medicines Initiative, IMI2)

May 22 – Monday
10.00 h - Nature-Inspired Biomaterials for Tissue Repair in Cardiovascular Applications: A Translational Story
Maria José Pereira - PhD (Head of Research at Gecko Biomedical)

16.30 h - To be announced
Aaron Schwarz- Director of R&D Innovation Sourcing at Novo Nordisk

May 23 - Tuesday
9.00 h - Bluepharma Pharmaceutical Industry SA: from development of generics to innovative research and site visit
Sérgio Simões - PhD
(Bluepharma address: Rua Bayer, 3045-016 São Martinho do Bispo - Coimbra; suggested transportation: bus no. 6, in front of the University Hospital or at Praça da República, http://www.smtuc.pt/avisos/index.php?id=490)

14.30 h - Photodynamic therapy in oncology
Cláudia Silva - PhD (Luzitin, SA)

16.00 h - Nanotechnology for drug targeting and the impact on drug development
João Nuno Moreira - PhD
Vera Moura - PhD (CEO of TREAT U, SA and CNC)
Nuno Fonseca  - PhD (TREAT U, SA, and CNC)

May 24 - Wednesday
11.00 h - Nanotechnology for drug and gene targeting and the impact on drug development (cont.)
Luís Pereira de Almeida - PhD (CNC)
Rui Nobre - PhD (CNC)
Liliana Mendonça - PhD (CNC)

16.00 h - Pharmacological and translational insights for antibodies and antibody drug conjugates
Daniel Lopes de Menezes - PhD (Biological Discovery California, Bristol-Myers Squibb)

May 25 - Thursday
10.30 h - The Role of Quality by Design in the Pharmaceutical Industry
Márcio Temtem - PhD (Associate Director Drug Product Development, Hovione, Portugal)

16.30 h - The science behind getting a drug approved faster
Frederico Cismondi - PhD (CEO & CO-founder of doDOC and Industry Program Director for MPP)

May 26 – Friday
9 h - Students presentations
back
 
© 2017 BEB - Doctoral Programme in Experimental Biology and Biomedicine powered by ponto.C